CPX promotes transcriptional-mediated downregulation of DJ-1, a potential biomarker for CRC diagnosis and prognosis, which results in the mitochondrial dysfunction, and thereby increases the levels of ROS. This evidence concerns the gene PARK7 and colorectal carcinoma.